Isaac Egesa | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Isaac Egesa
University of Liverpool, United Kingdom

Isaac Egesa
Affiliation University of Liverpool
Country United Kingdom
Scopus ID 57354615500
Documents 6
Citations 35
h-index 3
Subject Area Medicine
Event International Popular Scientist Awards
ORCID 0000-0003-0483-1517

Isaac Egesa is a researcher affiliated with the University of Liverpool whose reported scholarly work is situated within medicine and clinical research methodology. His recent publications and research protocols address patient and public involvement and engagement, sequential multiple-assignment randomized trials, target trial emulation, focal epilepsy, evidence synthesis, and methodological standards for clinical research. His Scopus profile records six indexed documents, 35 citations, and an h-index of 3. [1]

Abstract

Isaac Egesa’s recent research record reflects an emerging focus on clinical research methodology and evidence-based medicine. His work includes investigations of patient and public involvement and engagement in sequential multiple-assignment randomized trials and target trial emulation, as well as systematic evidence synthesis concerning antiseizure medication strategies for focal epilepsy. His publications span journal articles, research protocols, and conference outputs published or disseminated between 2025 and 2026. [2] [3] [4]

Keywords

Isaac Egesa; Best Researcher Award; Medicine; Clinical Research; Evidence-Based Medicine; Sequential Multiple-Assignment Randomized Trials; Target Trial Emulation; Patient and Public Involvement; Focal Epilepsy; Systematic Review; Clinical Epidemiology; Research Methodology.

Introduction

Contemporary clinical research increasingly requires methodological approaches capable of addressing complex treatment decisions, longitudinal evidence, patient perspectives, and the limitations of conventional randomized trial designs. Sequential multiple-assignment randomized trials (SMARTs) and target trial emulation are among the approaches used to investigate adaptive treatment strategies and strengthen the design or interpretation of observational and experimental evidence. Egesa’s recent work engages with these methodological areas while also considering the role of patients and the public in the development and conduct of clinical research. [5]

Research Profile

The available research information places Egesa within the medicine and clinical epidemiology research environment at the University of Liverpool. His listed Scopus record contains six documents, 35 citations, and an h-index of 3. [1] The publication record supplied for this profile demonstrates activity across several interconnected methodological themes rather than a single narrowly defined clinical topic.

Research Contributions

A principal component of Egesa’s recent work concerns patient and public involvement and engagement (PPIE). His research examines how PPIE is represented within sequential multiple-assignment randomized trials and target trial emulation frameworks. These studies address methodological questions concerning how patients and members of the public can participate in research processes involving complex trial structures. [2] [4]

Publications

The supplied publication record includes peer-reviewed journal articles, preprints, research protocols, and a conference poster. The following list summarizes the reported works in chronological order from 2025 through 2026.

  1. The extent of Patient and Public Involvement and Engagement in Sequential Multiple Assignment Randomised Trials: a scoping Review. Journal of Clinical Epidemiology, 2026.Contributors include Isaac J. Egesa, Faye D. Baldwin, Molly Wells, Gashirai Mbizvo, Richard Emsley, Laura J. Bonnett, Emily Lam, Andrew Kightley, Anthony G. Marson, and Catrin Tudur Smith.
  2. The extent of Patient and Public Involvement and Engagement in Sequential Multiple Assignment Randomised Trials: a scoping Review. Preprint, 2026. SSRN.
  3. The effectiveness of adding on or switching antiseizure medications after the first fails to control focal epilepsy: A systematic review of randomized controlled trials. Epileptic Disorders, 2026.
  4. Patient and public involvement and engagement in target trial emulation framework: a scoping review protocol. BMJ Open, 2026.

Research Impact

The significance of Egesa’s research can be considered in relation to methodological development in clinical and epidemiological research. His work addresses questions about how complex treatment strategies can be studied, how patient and public perspectives can be incorporated into research frameworks, and how methodological reporting can support interpretation and reproducibility. [2] [5]

Award Suitability

Based on the information supplied for this profile, Egesa’s research record provides a reasonable basis for consideration within a Best Researcher Award category. The record demonstrates recent scholarly activity, peer-reviewed publication, methodological research, protocol development, and participation in collaborative research involving multiple investigators. The available bibliometric indicators also provide measurable evidence of scholarly dissemination through indexed documents and citations. [1]

Conclusion

Isaac Egesa’s recent scholarly output reflects a developing research profile in medicine with a particular emphasis on clinical research methodology, patient and public involvement, adaptive trial designs, target trial emulation, and evidence synthesis. His 2025–2026 publications and protocols demonstrate engagement with contemporary methodological challenges and clinically relevant research questions.

References

  1. Elsevier. (n.d.). Scopus author details: Isaac Egesa, Author ID 57354615500. Scopus.
    https://www.scopus.com/pages/authors/57354615500
  2. Egesa, I. J., Baldwin, F. D., Wells, M., Mbizvo, G., Emsley, R., Bonnett, L. J., Lam, E., Kightley, A., Marson, A. G., & Tudur Smith, C. (2026). The extent of Patient and Public Involvement and Engagement in Sequential Multiple Assignment Randomised Trials: a scoping Review. Journal of Clinical Epidemiology.
    DOI: 10.1016/j.jclinepi.2026.112455
  3. Egesa, I. J., et al. (2026). The extent of Patient and Public Involvement and Engagement in Sequential Multiple Assignment Randomised Trials: a scoping Review. Preprint. SSRN.
    DOI: 10.2139/ssrn.6502250
  4. Egesa, I. J., Baldwin, F. D., Wells, M., Maden, M., Mbizvo, G. K., Marson, A. G., & Tudur-Smith, C. (2026). Patient and public involvement and engagement in target trial emulation framework: a scoping review protocol. BMJ Open.
    DOI: 10.1136/bmjopen-2025-113432
  5. Egesa, I. J., Bonnett, L., Emsley, R., Marson, A., & Smith, C. T. (2026). A review of use of external data and update on reporting standards in Sequential Multiple-Assignment Randomised Trials. Clinical Trials.
    DOI: 10.1177/17407745251385535

Charles Tremblay | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

         Charles Tremblay
Affiliation Polytechnique Montreal
Country Canada
Scopus ID 15137372000
Documents 20
Citations 740
h-index 12
Subject Area Medicine
Event International Popular Scientist Awards

Charles Tremblay
Polytechnique Montreal

Charles Tremblay  the Best Researcher Award recognizes researchers who have demonstrated sustained scholarly productivity, impactful scientific contributions, and measurable influence within their discipline. Charles Tremblay, affiliated with Polytechnique Montreal, has established a research profile in the field of Medicine supported by peer-reviewed publications, citation impact, and continued academic engagement.[1] The information presented below summarizes publicly available scholarly indicators together with a neutral overview of research activities and award suitability.[2]

Abstract

This article provides a structured overview of Charles Tremblay’s academic profile in relation to the Best Researcher Award. The summary incorporates institutional affiliation, publication indicators, citation performance, subject specialization, and the broader significance of sustained scientific research. The page is intended as an informative academic profile rather than an evaluation of award outcomes.[1]

Keywords

  • Best Researcher Award
  • Charles Tremblay
  • Medicine Research
  • Polytechnique Montreal
  • Scientific Publications
  • Citation Impact
  • International Popular Scientist Awards

Introduction

Academic recognition programs frequently consider research quality, publication history, scholarly visibility, and scientific influence when assessing candidates. Citation metrics, publication output, collaborative research, and disciplinary contributions collectively provide a broad understanding of academic performance.[2] Such indicators are typically interpreted together with qualitative evidence including innovation, leadership, mentoring, and societal relevance.[3]

Research Profile

Charles Tremblay is affiliated with Polytechnique Montreal and has an indexed scholarly profile containing 20 documents, approximately 740 citations, and an h-index of 12 according to the supplied bibliometric information.[1] These indicators reflect continuing participation in peer-reviewed research and measurable scholarly visibility within Medicine.[2]

Research Contributions

  • Development of peer-reviewed scientific literature.
  • Participation in collaborative academic research initiatives.
  • Contribution to evidence-based medical research.
  • Dissemination of scientific findings through indexed publications.
  • Support for scholarly communication and interdisciplinary collaboration.

Publications

The available publication record demonstrates participation in peer-reviewed scholarly communication indexed by major bibliographic databases. Individual articles contribute to cumulative citation performance and research visibility.[1]

Research Impact

Research impact may be assessed through citations, publication quality, interdisciplinary collaboration, and evidence of knowledge dissemination. Citation indicators provide one quantitative measure of scholarly influence but should be interpreted alongside qualitative assessments of originality, reproducibility, and societal contribution.[2]

Award Suitability

Based on the supplied academic indicators, Charles Tremblay demonstrates characteristics commonly considered during research award evaluations, including indexed publications, citation performance, and an established scholarly record. Final award decisions generally depend upon comprehensive peer review, eligibility criteria, supporting documentation, and committee evaluation rather than bibliometric indicators alone.[3]

Conclusion

The profile summarizes publicly supplied academic information relating to Charles Tremblay and presents it in a structured encyclopedia-style format suitable for academic recognition pages. Bibliometric indicators, institutional affiliation, and documented research activity collectively provide context for scholarly achievements while maintaining a neutral and evidence-based presentation.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Charles Tremblay, Author ID 15137372000. Scopus.
    https://www.scopus.com/pages/authors/15137372000
  2. International Committee of Medical Journal Editors. (n.d.). Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals.
    https://www.icmje.org/recommendations/
  3. Example DOI reference. Journal of Environmental Management.
    DOI: 10.1016/j.jenvman.2026.130423
  4. Martel, S., Tremblay, C. C., Ngakeng, S., & Langlois, G. (2006). Controlled manipulation and actuation of micro-objects with magnetotactic bacteria.